These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 16510290)
1. Design, synthesis, and evaluation of Leu*Ala hydroxyethylene-based non-peptide beta-secretase (BACE) inhibitors. Xiao K; Li X; Li J; Ma L; Hu B; Yu H; Fu Y; Wang R; Ma Z; Qiu B; Li J; Hu D; Wang X; Shen J Bioorg Med Chem; 2006 Jul; 14(13):4535-51. PubMed ID: 16510290 [TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of hydroxyethylene-based peptidomimetic inhibitors of human beta-secretase. Hom RK; Gailunas AF; Mamo S; Fang LY; Tung JS; Walker DE; Davis D; Thorsett ED; Jewett NE; Moon JB; John V J Med Chem; 2004 Jan; 47(1):158-64. PubMed ID: 14695829 [TBL] [Abstract][Full Text] [Related]
3. Aminoethylenes: a tetrahedral intermediate isostere yielding potent inhibitors of the aspartyl protease BACE-1. Yang W; Lu W; Lu Y; Zhong M; Sun J; Thomas AE; Wilkinson JM; Fucini RV; Lam M; Randal M; Shi XP; Jacobs JW; McDowell RS; Gordon EM; Ballinger MD J Med Chem; 2006 Feb; 49(3):839-42. PubMed ID: 16451048 [TBL] [Abstract][Full Text] [Related]
4. Modeling the binding affinities of beta-secretase inhibitors: application to subsite specificity. Rajamani R; Reynolds CH Bioorg Med Chem Lett; 2004 Oct; 14(19):4843-6. PubMed ID: 15341936 [TBL] [Abstract][Full Text] [Related]
5. Structure-based design and synthesis of macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors. Machauer R; Veenstra S; Rondeau JM; Tintelnot-Blomley M; Betschart C; Neumann U; Paganetti P Bioorg Med Chem Lett; 2009 Mar; 19(5):1361-5. PubMed ID: 19195886 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and preliminary evaluation of peptidomimetic inhibitors of human beta-secretase. Niu Y; Wang Y; Zou X; Yang X; Ma C; Lü Y; Zhou B; Yuan Y; Du G; Xu P Eur J Med Chem; 2010 May; 45(5):2089-94. PubMed ID: 20153560 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors. Lindsley SR; Moore KP; Rajapakse HA; Selnick HG; Young MB; Zhu H; Munshi S; Kuo L; McGaughey GB; Colussi D; Crouthamel MC; Lai MT; Pietrak B; Price EA; Sankaranarayanan S; Simon AJ; Seabrook GR; Hazuda DJ; Pudvah NT; Hochman JH; Graham SL; Vacca JP; Nantermet PG Bioorg Med Chem Lett; 2007 Jul; 17(14):4057-61. PubMed ID: 17482814 [TBL] [Abstract][Full Text] [Related]
8. Naphthyl and coumarinyl biarylpiperazine derivatives as highly potent human beta-secretase inhibitors. Design, synthesis, and enzymatic BACE-1 and cell assays. Garino C; Tomita T; Pietrancosta N; Laras Y; Rosas R; Herbette G; Maigret B; Quéléver G; Iwatsubo T; Kraus JL J Med Chem; 2006 Jul; 49(14):4275-85. PubMed ID: 16821787 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues. Bäck M; Nyhlén J; Kvarnström I; Appelgren S; Borkakoti N; Jansson K; Lindberg J; Nyström S; Hallberg A; Rosenquist S; Samuelsson B Bioorg Med Chem; 2008 Nov; 16(21):9471-86. PubMed ID: 18842420 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of potent BACE-1 inhibitors incorporating a hydroxyethylene isostere as central core. Wångsell F; Gustafsson K; Kvarnström I; Borkakoti N; Edlund M; Jansson K; Lindberg J; Hallberg A; Rosenquist A; Samuelsson B Eur J Med Chem; 2010 Mar; 45(3):870-82. PubMed ID: 20036448 [TBL] [Abstract][Full Text] [Related]
11. Preorganization of the hydroxyethylene dipeptide isostere: the preferred conformation in solution resembles the conformation bound to BACE. Vidal P; Timm D; Broughton H; Chen SH; Martín JA; Rivera-Sagredo A; McCarthy JR; Shapiro MJ; Espinosa JF J Med Chem; 2005 Dec; 48(24):7623-7. PubMed ID: 16302802 [TBL] [Abstract][Full Text] [Related]
12. P2'-truncated BACE-1 inhibitors with a novel hydroxethylene-like core. Meredith JA; Björklund C; Adolfsson H; Jansson K; Hallberg A; Rosenquist A; Samuelsson B Eur J Med Chem; 2010 Feb; 45(2):542-54. PubMed ID: 19995674 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of potent and selective BACE-1 inhibitors. Björklund C; Oscarson S; Benkestock K; Borkakoti N; Jansson K; Lindberg J; Vrang L; Hallberg A; Rosenquist A; Samuelsson B J Med Chem; 2010 Feb; 53(4):1458-64. PubMed ID: 20128595 [TBL] [Abstract][Full Text] [Related]
14. Hydroxytriamides as potent gamma-secretase inhibitors. Prasad CV; Wallace OB; Noonan JW; Sloan CP; Lau W; Vig S; Parker MF; Smith DW; Hansel SB; Polson CT; Barten DM; Felsenstein KM; Roberts SB Bioorg Med Chem Lett; 2004 Apr; 14(8):1917-21. PubMed ID: 15050627 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and SAR of hydroxyethylamine based phenylcarboxyamides as inhibitors of BACE. Wu YJ; Zhang Y; Good AC; Burton CR; Toyn JH; Albright CF; Macor JE; Thompson LA Bioorg Med Chem Lett; 2009 May; 19(10):2654-60. PubMed ID: 19375914 [TBL] [Abstract][Full Text] [Related]
16. Construction of a small peptide library related to inhibitor OM99-2 and its structure-activity relationship to beta-secretase. Hu B; Xiong B; Qiu BY; Li X; Yu HP; Xiao K; Wang X; Li J; Shen JK Acta Pharmacol Sin; 2006 Dec; 27(12):1586-93. PubMed ID: 17112413 [TBL] [Abstract][Full Text] [Related]